Doctor of Medicine and Master of Science in Clinical Investigation

Offered in collaboration with our Clinical and Translational Science Institute, NYU Grossman School of Medicine's dual MD/MS in Clinical Investigation (MSCI) with a specialized focus on translational research is designed for students who want to pursue a career in translational researchapplying research advances to the development of new medical therapies.

As a student in this dual degree program, you take courses on topics including research design, biostatistics, epidemiology, drug design, and manuscript writing. You also complete an original research project under the guidance of a faculty mentor and the program director.

In weekly seminars, you exchange ideas with other students, discuss problems encountered during your research, and develop solutions. This experience allows you to be part of our vibrant community of researchers.

Throughout the program, your faculty mentor and the program director track your progress and set benchmarks, which include submitting research abstracts and manuscripts for publication and presenting at national research meetings. The program culminates with a written thesis and oral defense based on your original research.

To be eligible, applicants must meet several criteria:
have a bachelor's degree from an accredited college or university in the United States or Canada
we also accept applications from international students who have a bachelor's degree from an accredited college or university in the United States or Canada
the Medical College Admission Test (MCAT) is required for all applicants
Our MD program candidates are knowledgeable in core scientific subjects and demonstrate strong communication skills, which form the foundation necessary for success in medical school.
Applicants to NYU Grossman School of Medicine must hold a bachelor's degree from an accredited college or university in the United States or Canada.
The median and average undergraduate GPAs for students in our most recent incoming class were 3.97 and 3.95, respectively.
Letters of Evaluation